| Literature DB >> 7802755 |
M S Keshavan1, J Stecker, R K Kambhampati.
Abstract
We describe a patient with marked elevations of creatine kinase following institution of clozapine treatment. The enzyme levels promptly subsided with discontinuation of clozapine. The clinical features did not meet any of the published criteria for neuroleptic malignant syndrome.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7802755 DOI: 10.1192/bjp.164.1.118
Source DB: PubMed Journal: Br J Psychiatry ISSN: 0007-1250 Impact factor: 9.319